{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T08:49:24Z","timestamp":1778057364849,"version":"3.51.4"},"reference-count":81,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2011,7,20]],"date-time":"2011-07-20T00:00:00Z","timestamp":1311120000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0022090","type":"journal-article","created":{"date-parts":[[2011,7,20]],"date-time":"2011-07-20T20:54:07Z","timestamp":1311195247000},"page":"e22090","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":31,"title":["Genetic Cross-Interaction between APOE and PRNP in Sporadic Alzheimer's and Creutzfeldt-Jakob Diseases"],"prefix":"10.1371","volume":"6","author":[{"given":"Olga","family":"Calero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda J.","family":"Bullido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordi","family":"Clarim\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Frank-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo","family":"Mart\u00ednez-Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Lle\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Jes\u00fas","family":"Rey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"R\u00e1bano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Blesa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"G\u00f3mez-Isla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Valdivieso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jes\u00fas","family":"de Pedro-Cuesta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isidro","family":"Ferrer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Calero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2011,7,20]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/ndt\/13.suppl_7.33","article-title":"Human brain amyloidoses.","volume":"13","author":"P Gambetti","year":"1998","journal-title":"Nephrol Dial Transplant"},{"issue":"12","key":"ref2","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S0166-2236(02)02263-4","article-title":"Alzheimer's and prion diseases: distinct pathologies, common proteolytic denominators.","volume":"25","author":"F Checler","year":"2002","journal-title":"Trends Neurosci"},{"issue":"5646","key":"ref3","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1126\/science.1087348","article-title":"Games played by rogue proteins in prion disorders and Alzheimer's disease.","volume":"302","author":"A Aguzzi","year":"2003","journal-title":"Science"},{"issue":"2","key":"ref4","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1440-1789.2005.00605.x","article-title":"Overlap between neurodegenerative disorders.","volume":"25","author":"RA Armstrong","year":"2005","journal-title":"Neuropathology"},{"issue":"8","key":"ref5","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.tibs.2006.06.006","article-title":"Delineating common molecular mechanisms in Alzheimer's and prion diseases.","volume":"31","author":"KJ Barnham","year":"2006","journal-title":"Trends Biochem Sci"},{"issue":"5123","key":"ref6","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.","volume":"261","author":"EH Corder","year":"1993","journal-title":"Science"},{"issue":"8","key":"ref7","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1212\/WNL.43.8.1467","article-title":"Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease.","volume":"43","author":"AM Saunders","year":"1993","journal-title":"Neurology"},{"issue":"3","key":"ref8","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/sj.ejhg.5201544","article-title":"Prion disease genetics.","volume":"14","author":"S Mead","year":"2006","journal-title":"Eur J Hum Genet"},{"issue":"2","key":"ref9","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1212\/01.WNL.0000103290.74549.DC","article-title":"Polymorphisms within the prion (PrP) and prion-like protein (Doppel) genes in AD.","volume":"62","author":"E Golanska","year":"2004","journal-title":"Neurology"},{"issue":"2","key":"ref10","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1212\/01.WNL.0000130198.72589.69","article-title":"Prion protein codon 129 polymorphism and risk of Alzheimer disease.","volume":"63","author":"M Riemenschneider","year":"2004","journal-title":"Neurology"},{"issue":"11","key":"ref11","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1007\/s00702-006-0540-4","article-title":"Prion protein gene M129 allele is a risk factor for Alzheimer's disease.","volume":"113","author":"M Gacia","year":"2006","journal-title":"J Neural Transm"},{"issue":"4","key":"ref12","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1212\/WNL.55.4.593","article-title":"Polymorphism at codon 129 of the prion protein gene is not associated with sporadic AD.","volume":"55","author":"O Combarros","year":"2000","journal-title":"Neurology"},{"issue":"2","key":"ref13","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1136\/jnnp.71.2.279","article-title":"Prion protein gene polymorphism and Alzheimer's disease: one modulatory trait of cognitive decline?","volume":"71","author":"VM Casadei","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"ref14","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/ana.10507","article-title":"PRNP Val129 homozygosity increases risk for early-onset Alzheimer's disease.","volume":"53","author":"B Dermaut","year":"2003","journal-title":"Ann Neurol"},{"issue":"6","key":"ref15","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/ana.20646","article-title":"Prion protein codon 129 genotype prevalence is altered in primary progressive aphasia.","volume":"58","author":"X Li","year":"2005","journal-title":"Ann Neurol"},{"issue":"5","key":"ref16","doi-asserted-by":"crossref","first-page":"770.e1","DOI":"10.1016\/j.neurobiolaging.2005.05.025","article-title":"Is M129V of PRNP gene associated with Alzheimer's disease? A case-control study and a meta-analysis.","volume":"27","author":"R Del Bo","year":"2006","journal-title":"Neurobiol Aging"},{"issue":"2","key":"ref17","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1468-1331.2007.02021.x","article-title":"Codon 129 polymorphism of prion protein gene in sporadic Alzheimer's disease.","volume":"15","author":"A Poleggi","year":"2008","journal-title":"Eur J Neurol"},{"key":"ref18","article-title":"No replication of genetic association between candidate polymorphisms and Alzheimer's disease.","author":"E Cousin","year":"2009","journal-title":"Neurobiol Aging"},{"issue":"1","key":"ref19","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s10048-008-0151-3","article-title":"Assessment of Alzheimer's disease case-control associations using family-based methods.","volume":"10","author":"BM Schjeide","year":"2009","journal-title":"Neurogenetics"},{"issue":"8933","key":"ref20","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/S0140-6736(94)90691-2","article-title":"The apolipoprotein E alleles as major susceptibility factors for Creutzfeldt-Jakob disease. The French Research Group on Epidemiology of Human Spongiform Encephalopathies.","volume":"344","author":"P Amouyel","year":"1994","journal-title":"Lancet"},{"issue":"1\u20132","key":"ref21","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0304-3940(01)02264-9","article-title":"Influence of the prion protein and the apolipoprotein E genotype on the Creutzfeldt-Jakob Disease phenotype.","volume":"313","author":"B Van Everbroeck","year":"2001","journal-title":"Neurosci Lett"},{"issue":"8873","key":"ref22","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/0140-6736(93)91709-U","article-title":"Apolipoprotein E epsilon 4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases.","volume":"342","author":"AM Saunders","year":"1993","journal-title":"Lancet"},{"issue":"8941","key":"ref23","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0140-6736(95)91196-0","article-title":"Apolipoprotein E in Creutzfeldt-Jakob disease.","volume":"345","author":"I Zerr","year":"1995","journal-title":"Lancet"},{"issue":"2","key":"ref24","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0304-3940(95)12030-8","article-title":"Apolipoprotein E in sporadic and familial Creutzfeldt-Jakob disease.","volume":"199","author":"M Salvatore","year":"1995","journal-title":"Neurosci Lett"},{"issue":"2","key":"ref25","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0167-4943(96)00750-9","article-title":"Apolipoprotein Eepsilon4 allele, a risk factor for late onset nonfamilial Alzheimer's disease among Israeli Jews.","volume":"24","author":"G Friedman","year":"1997","journal-title":"Arch Gerontol Geriatr"},{"issue":"12","key":"ref26","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1001\/archneur.1996.00550120041014","article-title":"Apolipoprotein E phenotype frequency and cerebrospinal fluid concentration are not associated with Creutzfeldt-Jakob disease.","volume":"53","author":"I Zerr","year":"1996","journal-title":"Arch Neurol"},{"issue":"4","key":"ref27","doi-asserted-by":"crossref","first-page":"717","DOI":"10.3233\/JAD-2010-101527","article-title":"Amyloid-\u03b2 1\u201342 levels are modified by apolipoprotein E \u03b54 in Creutzfeldt-Jakob disease in a similar manner as in Alzheimer's disease.","volume":"23","author":"D Varges","year":"2011","journal-title":"J Alzheimers Dis"},{"issue":"8","key":"ref28","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1212\/WNL.57.8.1482","article-title":"The effects of APOE genotype on age at onset and progression of neurodegenerative diseases.","volume":"57","author":"J Chapman","year":"2001","journal-title":"Neurology"},{"issue":"2","key":"ref29","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/ng0694-180","article-title":"Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease.","volume":"7","author":"EH Corder","year":"1994","journal-title":"Nat Genet"},{"issue":"2","key":"ref30","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0304-3940(95)11353-3","article-title":"Allelic variations in apolipoprotein E and prion protein genotype related to plaque formation and age of onset in sporadic Creutzfeldt-Jakob disease.","volume":"187","author":"SM Pickering-Brown","year":"1995","journal-title":"Neurosci Lett"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/bmb\/66.1.213","article-title":"Sporadic and familial CJD: classification and characterisation.","volume":"66","author":"P Gambetti","year":"2003","journal-title":"Br Med Bull"},{"issue":"Pt 6","key":"ref32","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1093\/brain\/awg125","article-title":"Molecular classification of sporadic Creutzfeldt-Jakob disease.","volume":"126","author":"AF Hill","year":"2003","journal-title":"Brain"},{"issue":"3","key":"ref33","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1212\/WNL.51.3.734","article-title":"Polymorphism of the prion protein is associated with cognitive impairment in the elderly: the EVA study.","volume":"51","author":"C Berr","year":"1998","journal-title":"Neurology"},{"issue":"4","key":"ref34","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1159\/000119730","article-title":"Survival in Alzheimer's disease is shorter in women carrying heterozygosity at codon 129 of the PRNP gene and no APOE epsilon 4 allele.","volume":"25","author":"C Giannattasio","year":"2008","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"26","key":"ref35","doi-asserted-by":"crossref","first-page":"11062","DOI":"10.1073\/pnas.0609621104","article-title":"Cellular prion protein regulates beta-secretase cleavage of the Alzheimer's amyloid precursor protein.","volume":"104","author":"ET Parkin","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"ref36","doi-asserted-by":"crossref","first-page":"190","DOI":"10.4161\/pri.3.4.9980","article-title":"Prion protein and Alzheimer disease.","volume":"3","author":"KA Kellett","year":"2009","journal-title":"Prion"},{"issue":"11","key":"ref37","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1001\/archneurol.2009.223","article-title":"Cellular prion protein mediates the toxicity of beta-amyloid oligomers: implications for Alzheimer disease.","volume":"66","author":"HB Nygaard","year":"2009","journal-title":"Arch Neurol"},{"issue":"7233","key":"ref38","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/nature07761","article-title":"Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers.","volume":"457","author":"J Laur\u00e9n","year":"2009","journal-title":"Nature"},{"issue":"4","key":"ref39","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00109-009-0568-7","article-title":"Beta-amyloid oligomers and cellular prion protein in Alzheimer's disease.","volume":"88","author":"EC Gunther","year":"2010","journal-title":"J Mol Med"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/1471-2202-11-130","article-title":"Anti-PrPC monoclonal antibody infusion as a novel treatment for cognitive deficits in an Alzheimer's disease model mouse.","volume":"11","author":"E Chung","year":"2010","journal-title":"BMC Neurosci"},{"issue":"18","key":"ref41","doi-asserted-by":"crossref","first-page":"6367","DOI":"10.1523\/JNEUROSCI.0395-10.2010","article-title":"Memory impairment in transgenic Alzheimer mice requires cellular prion protein.","volume":"5;30","author":"DA Gimbel","year":"2010","journal-title":"J Neurosci"},{"issue":"14","key":"ref42","doi-asserted-by":"crossref","first-page":"6381","DOI":"10.1073\/pnas.90.14.6381","article-title":"Alzheimer disease and the prion disorders amyloid beta-protein and prion protein amyloidoses.","volume":"90","author":"DL Price","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"ref43","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1136\/jnnp.2009.188425","article-title":"Nosocomial transmission of sporadic Creutzfeldt-Jakob disease: results from a risk-based assessment of surgical interventions.","volume":"82","author":"J de Pedro-Cuesta","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"ref44","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ng1934","article-title":"Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database.","volume":"39","author":"L Bertram","year":"2007","journal-title":"Nat Genet"},{"issue":"9","key":"ref45","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.neurobiolaging.2007.11.027","article-title":"Epistasis in sporadic Alzheimer's disease.","volume":"30","author":"O Combarros","year":"2009","journal-title":"Neurobiol Aging"},{"issue":"4","key":"ref46","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1159\/000278692","article-title":"Clinical features of rapidly progressive Alzheimer's disease.","volume":"29","author":"C Schmidt","year":"2010","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"6","key":"ref47","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1159\/000121389","article-title":"Association between deposition of beta-amyloid and pathological prion protein in sporadic Creutzfeldt-Jakob disease.","volume":"5","author":"L Debatin","year":"2008","journal-title":"Neurodegener Dis"},{"issue":"2","key":"ref48","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s004010050870","article-title":"Coexistence of Alzheimer-type neuropathology in Creutzfeldt-Jakob disease.","volume":"96","author":"JA Hainfellner","year":"1998","journal-title":"Acta Neuropathol"},{"issue":"1","key":"ref49","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s004010000271","article-title":"Prion protein expression in senile plaques in Alzheimer's disease.","volume":"101","author":"I Ferrer","year":"2001","journal-title":"Acta Neuropathol"},{"issue":"5","key":"ref50","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s004010100405","article-title":"Marked increase of neuronal prion protein immunoreactivity in Alzheimer's disease and human prion diseases.","volume":"101","author":"T Voigtl\u00e4nder","year":"2001","journal-title":"Acta Neuropathol"},{"issue":"3","key":"ref51","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0304-3940(02)00668-7","article-title":"The prion protein in human neurodegenerative disorders.","volume":"329","author":"GG Kovacs","year":"2002","journal-title":"Neurosci Lett"},{"key":"ref52","article-title":"Accumulation of cellular prion protein within dystrophic neurites of amyloid plaques in the Alzheimer's disease brain.","volume":"2010 Nov 9","author":"RH Takahashi","year":"2010","journal-title":"Neuropathology"},{"issue":"13","key":"ref53","doi-asserted-by":"crossref","first-page":"4528","DOI":"10.1523\/JNEUROSCI.5924-09.2010","article-title":"Molecular cross talk between misfolded proteins in animal models of Alzheimer's and prion diseases.","volume":"30","author":"R Morales","year":"2010","journal-title":"J Neurosci"},{"key":"ref54","article-title":"Lipid Rafts: Linking Alzheimer's Amyloid-\u03b2 Production, Aggregation, and Toxicity at Neuronal Membranes.","volume":"2010 Dec 27","author":"JV Rushworth","year":"2010","journal-title":"Int J Alzheimers Dis"},{"key":"ref55","article-title":"High ability of apolipoprotein E4 to stabilize amyloid-\u03b2 peptide oligomers, the pathological entities responsible for Alzheimer's disease.","author":"E Cerf","year":"2011","journal-title":"FASEB J"},{"issue":"3","key":"ref56","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.neuron.2009.06.026","article-title":"The role of apolipoprotein E in Alzheimer's disease.","volume":"63","author":"J Kim","year":"2009","journal-title":"Neuron"},{"issue":"5","key":"ref57","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nrn2620","article-title":"Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy.","volume":"10","author":"G Bu","year":"2009","journal-title":"Nat Rev Neurosci"},{"issue":"2","key":"ref58","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3233\/JAD-2010-100141","article-title":"APOE genotype results in differential effects on the peripheral clearance of amyloid-beta42 in APOE knock-in and knock-out mice.","volume":"21","author":"MJ Sharman","year":"2010","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"ref59","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/prot.22891","article-title":"A differential association of Apolipoprotein E isoforms with the amyloid-\u03b2 oligomer in solution.","volume":"79","author":"J Petrlova","year":"2011","journal-title":"Proteins"},{"issue":"1","key":"ref60","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1471-4159.2004.03007.x","article-title":"Multiple pathways of apolipoprotein E signaling in primary neurons.","volume":"93","author":"HS Hoe","year":"2005","journal-title":"J Neurochem"},{"issue":"6","key":"ref61","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.cell.2009.05.042","article-title":"Bridging physiology and pathology in AD.","volume":"137","author":"D Kim","year":"2009","journal-title":"Cell"},{"issue":"6333","key":"ref62","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/352340a0","article-title":"Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease.","volume":"352","author":"MS Palmer","year":"1991","journal-title":"Nature"},{"issue":"49","key":"ref63","doi-asserted-by":"crossref","first-page":"13258","DOI":"10.1523\/JNEUROSCI.3109-08.2008","article-title":"Aggregated, wild-type prion protein causes neurological dysfunction and synaptic abnormalities.","volume":"28","author":"R Chiesa","year":"2008","journal-title":"J Neurosci"},{"issue":"5","key":"ref64","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/j.1440-1789.2009.01007.x","article-title":"Prion protein oligomers in Creutzfeldt-Jakob disease detected by gel-filtration centrifuge columns.","volume":"29","author":"H Minaki","year":"2009","journal-title":"Neuropathology"},{"issue":"2","key":"ref65","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.nbd.2008.02.001","article-title":"Fibrillar prion peptide PrP(106\u2013126) treatment induces Dab1 phosphorylation and impairs APP processing and Abeta production in cortical neurons.","volume":"30","author":"R Gav\u00edn","year":"2008","journal-title":"Neurobiol Dis"},{"issue":"2","key":"ref66","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.nbd.2009.10.010","article-title":"Involvement of Dab1 in APP processing and beta-amyloid deposition in sporadic Creutzfeldt-Jakob patients.","volume":"37","author":"R Gav\u00edn","year":"2010","journal-title":"Neurobiol Dis"},{"issue":"2","key":"ref67","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1172\/JCI113107","article-title":"Intestinal cholesterol absorption efficiency in man is related to apoprotein E phenotype.","volume":"80","author":"YA Kes\u00e4niemi","year":"1987","journal-title":"J Clin Invest"},{"issue":"3","key":"ref68","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/00041433-199906000-00003","article-title":"Apolipoprotein E: from atherosclerosis to Alzheimer's disease and beyond.","volume":"10","author":"RW Mahley","year":"1999","journal-title":"Curr Opin Lipidol"},{"issue":"2","key":"ref69","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.mcn.2005.10.008","article-title":"The prion protein requires cholesterol for cell surface localization.","volume":"31","author":"S Gilch","year":"2006","journal-title":"Mol Cell Neurosci"},{"issue":"6","key":"ref70","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.molmed.2010.04.004","article-title":"Abeta-independent roles of apolipoprotein E4 in the pathogenesis of Alzheimer's disease.","volume":"16","author":"Y Huang","year":"2010","journal-title":"Trends Mol Med"},{"issue":"5619","key":"ref71","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1126\/science.1083320","article-title":"Balancing selection at the prion protein gene consistent with prehistoric kurulike epidemics.","volume":"300","author":"S Mead","year":"2003","journal-title":"Science"},{"issue":"1","key":"ref72","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/ajpa.21298","article-title":"Worldwide allele frequencies of the human apolipoprotein E gene: climate, local adaptations, and evolutionary history.","volume":"143","author":"DT Eisenberg","year":"2010","journal-title":"Am J Phys Anthropol"},{"issue":"2","key":"ref73","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1101\/gr.4345506","article-title":"The prion protein gene in humans revisited: lessons from a worldwide resequencing study.","volume":"16","author":"M Soldevila","year":"2006","journal-title":"Genome Res"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1023\/A:1013316611768","article-title":"Epistasis, complex traits, and mapping genes.","volume":"112\u2013113","author":"MJ Wade","year":"2001","journal-title":"Genetica"},{"issue":"6","key":"ref75","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/bies.20236","article-title":"Traversing the conceptual divide between biological and statistical epistasis: systems biology and a more modern synthesis.","volume":"27","author":"JH Moore","year":"2005","journal-title":"Bioessays"},{"issue":"2","key":"ref76","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3233\/JAD-2009-1055","article-title":"Earlier onset of Alzheimer's disease: risk polymorphisms within PRNP, PRND, CYP46, and APOE genes.","volume":"17","author":"E Golanska","year":"2009","journal-title":"J Alzheimers Dis"},{"issue":"7","key":"ref77","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.","volume":"34","author":"G McKhann","year":"1984","journal-title":"Neurology"},{"issue":"2","key":"ref78","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jneumeth.2009.06.033","article-title":"Apolipoprotein E genotyping method by real time PCR, a fast and cost-effective alternative to the TaqMan and FRET assays.","volume":"183","author":"O Calero","year":"2009","journal-title":"J Neurosci Methods"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.mcp.2004.03.003","article-title":"SNP genotyping with FRET probes. Optimizing the resolution of heterozygotes.","volume":"18","author":"A Mart\u00ednez-Garc\u00eda","year":"2004","journal-title":"Mol Cell Probes"},{"issue":"3","key":"ref80","doi-asserted-by":"crossref","first-page":"146","DOI":"10.4161\/pri.3.3.9339","article-title":"Allelic discrimination of genetic human prion diseases by real-time PCR genotyping.","volume":"3","author":"O Calero","year":"2009","journal-title":"Prion"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/1756-0500-2-105","article-title":"The synergy factor: a statistic to measure interactions in complex diseases.","volume":"2","author":"M Cortina-Borja","year":"2009","journal-title":"BMC Res Notes"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0022090","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,21]],"date-time":"2020-06-21T13:10:53Z","timestamp":1592745053000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0022090"}},"subtitle":[],"editor":[{"given":"Andrew Francis","family":"Hill","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2011,7,20]]},"references-count":81,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2011,7,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0022090","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,20]]}}}